Review
Anti-inflammatory mechanisms of bioactive milk proteins in the intestine of newborns

https://doi.org/10.1016/j.biocel.2013.04.028Get rights and content

Abstract

The human newborn infant is susceptible to gut inflammatory disorders. In particular, growth-restricted infants or infants born prematurely may develop a severe form of intestinal inflammation known as necrotizing enterocolitis (NEC), which has a high mortality. Milk provides a multitude of proteins with anti-inflammatory properties and in this review we gather together some recent significant advances regarding the isolation and proteomic identification of these minor constituents of both human and bovine milk. We introduce the process of inflammation, with a focus on the immature gut, and describe how a multitude of milk proteins act against the inflammatory process according to both in vitro and in vivo studies. We highlight the effects of milk proteins such as caseins, and of whey proteins such as alpha-lactalbumin, beta-lactoglobulin, lactoferrin, osteopontin, immunoglobulins, trefoil factors, lactoperoxidase, superoxide dismutase, platelet-activating factor acetylhydrolase, alkaline phosphatase, and growth factors (TGF-β, IGF-I and IGF-II, EGF, HB-EGF). The effects of milk fat globule proteins, such as TLR-2, TLR-4, sCD14 and MFG-E8/lactadherin, are also discussed. Finally, we indicate how milk proteins could be useful for the prophylaxis and therapy of intestinal inflammation in infants and children.

Introduction

Before birth, the gastrointestinal tract (GIT) has matured to digest human milk and to tolerate the invasion by billions of bacteria. It produces mucins and defensins and has normal proliferation, restitution and cellular homeostasis. Not surprisingly, GIT inflammatory reactions are common in newborn infants, particularly in compromised infants such as those born preterm and/or growth-restricted. The most severe GIT inflammatory condition of very preterm infants is necrotizing enterocolitis (NEC), which has a high mortality (10–50%, Uauy et al., 1991, Neu and Walker, 2011b). Causative factors of NEC in preterm newborns include reduced peristalsis, impaired epithelial barrier function and GIT immaturity characterized by impaired enterocyte restitution (Fig. 1). Other factors include a leaky mucosal barrier, dys-colonization, bacterial translocation, reduced mesenteric perfusion and excessive milk feeding. The type of milk diet is also important as formula feeding may lead to a different bacterial colonization and function of the gut, relative to mother's milk or donor human milk (Lin and Stoll, 2006, Henry and Moss, 2009).

Studies in both infants and animal models suggest that human milk protects against NEC, while formula-feeding could predispose to NEC (Maayan-Metzger et al., 2012, Moller et al., 2011, Sangild et al., 2006, Nadler et al., 2000). In this review, we use the interactions between human and bovine milk components and NEC development to illustrate how milk bioactive proteins may act as anti-inflammatory agents. We refer also to studies on the effects of milk proteins against experimentally induced colitis in more mature rodent models. Although there are differences between colitis and NEC, similarities between these two forms of inflammation exist (Pothoulakis et al., 1998). Likewise, there are similarities to the pro-inflammatory state induced by parenteral feeding, and in both piglets and rodent models intake of milk components exert marked effects in this state (Liu et al., 2009). We highlight these as potential mechanisms by which human and bovine milk proteins protect against inflammation in the neonate. The main focus is on the direct anti-inflammatory actions of human and bovine milk proteins on intestinal cells although it is acknowledged that part of the effects also may be mediated indirectly via the anti-bacterial effects of milk components. We focus on mature bovine and human milk, acknowledging the fact that many of the milk growth factors, immunomodulatory components and antimicrobials are found in highest concentrations in colostrum, the milk secreted during the first days after birth.

Section snippets

Toll-like receptor activation

The newborn GIT is susceptible to lipopolysaccharide (LPS) derived from Gram-negative bacteria and binds to TLR-4. Immature human fetal enterocytes express TLR-4 constitutively and after LPS stimulation levels of TLR-4 decrease suggesting regulation of receptor levels by inflammatory stimuli (Fusunyan et al., 2001). TLR-4 mRNA expression is lower in preterm than in term pigs (Bering et al., 2012) but in human preterm infants, LPS increases TLR-4, sensitizing to further endotoxin (Leaphart et

Milk protein composition

Milk proteins can be administered to newborns by three main routes. Firstly, during breast-feeding, secondly via feeding of donor milk and thirdly via administration of infant formula, based on bovine milk proteins. Milk proteins consist of two main classes, caseins, and whey proteins. General aspects of individual proteins discussed in this review are indicated (Table 1).

An important difference between human and bovine milk is that bovine milk contains beta-lactoglobulin (β-Lg), whereas human

Caseins (CN)

Upon feeding, buffer capacity of human milk rapidly increases gastric pH to ∼pH 7. Depending on the feeding frequency, pH falls over the following 2–4 h, reaching ∼pH 4, but as low as pH 3–3.5 in a minority of infants (Mason, 1962). The buffering effect of human and bovine milk proteins prevents gastric pH from not reaching the optimum of enzymes such as pepsin A and pepsin C (gastricsin) (∼pH 2). This results in only minor initial digestion of human milk proteins. However, pH is sufficient to

Protective effects of milk proteins against necrotizing enterocolitis

In the previous sections we have provided evidence for the anti-inflammatory effects of many human and bovine milk proteins. In its most severe form in newborns, GIT inflammation develops into NEC. There are reports regarding the effects of bovine milk proteins, both to induce NEC, or to protect against NEC. Rat formula milk overfeeding can stimulate NEC-like enterocolitis in premature rat pups (Okada et al., 2010), but evidence generally points to a protective effect of both human and bovine

Future prospects

A future challenge is to ensure that the composition of infant milk formulas, and their milk fortifiers are optimized to provide an adequate supply of anti-inflammatory proteins, especially for sensitive newborns. A key point is that the technological processing of both human and bovine milk destroys milk bioactive proteins to a variable degree and that production methods should try to avoid this loss which will also improve the alimentation of newborns. For instance, heat-induced aggregation

Acknowledgments

We acknowledge the support from The Strategic Research Councils, Danish Dairy Foundation and ARLA Foods in doing experimental studies in this area and in preparing the present review.

References (320)

  • M. Caplan et al.

    Serum PAF acetylhydrolase increases during neonatal maturation

    Prostaglandins

    (1990)
  • C. Castellote et al.

    Premature delivery influences the immunological composition of colostrum and transitional and mature human milk

    Journal of Nutrition

    (2011)
  • J.M. Cavaillon

    Cytokines and macrophages

    Biomedicine & Pharmacotherapy

    (1994)
  • B. Chabance et al.

    Casein peptide release and passage to the blood in humans during digestion of milk or yogurt

    Biochimie

    (1998)
  • D.E.W. Chatterton et al.

    In vitro digestion of novel milk protein ingredients for use in infant formulas: research on biological functions

    Trends in Food Science & Technology

    (2004)
  • D.E.W. Chatterton et al.

    Bioactivity of beta-lactoglobulin and alpha-lactalbumin—technological implications for processing

    International Dairy Journal

    (2006)
  • N.K. Chokshi et al.

    The role of nitric oxide in intestinal epithelial injury and restitution in neonatal necrotizing enterocolitis

    Seminars in Perinatology

    (2008)
  • B. Christensen et al.

    Cell type-specific post-translational modifications of mouse osteopontin are associated with different adhesive properties

    Journal of Biological Chemistry

    (2007)
  • C.S. Curran et al.

    Lactoferrin activates macrophages via TLR4-dependent and -independent signaling pathways

    Cellular Immunology

    (2006)
  • A.P. da Silva et al.

    Osteopontin attenuation of dextran sulfate sodium-induced colitis in mice

    Laboratory Investigation

    (2009)
  • A. Daddaoua et al.

    Bovine glycomacropeptide is anti-inflammatory in rats with hapten-induced colitis

    Journal of Nutrition

    (2005)
  • Y. Denizot et al.

    Paf-acether production by Escherichia coli

    Biochemical and Biophysical Research Communications

    (1989)
  • R. Derynck et al.

    TGF-beta receptor signaling

    Biochimica et Biophysica Acta

    (1997)
  • K.G. Dewey et al.

    Differences in morbidity between breast-fed and formula-fed infants

    Journal of Pediatrics

    (1995)
  • B. Dutta et al.

    Cloning, expression, purification, and immunocharacterization of placental protein-14

    Protein Expression and Purification

    (1998)
  • B. Dvorak

    Milk epidermal growth factor and gut protection

    Journal of Pediatrics

    (2010)
  • B. Ek-Rylander et al.

    Osteoclast migration on phosphorylated osteopontin is regulated by endogenous tartrate-resistant acid phosphatase

    Experimental Cell Research

    (2010)
  • L. Elfstrand et al.

    Immunoglobulins, growth factors and growth hormone in bovine colostrum and the effects of processing

    International Dairy Journal

    (2002)
  • P.M. Emmett et al.

    Properties of human milk and their relationship with maternal nutrition

    Early Human Development

    (1997)
  • Y. Endo et al.

    The role of ficolins in the lectin pathway of innate immunity

    International Journal of Biochemistry and Cell Biology

    (2011)
  • U. Eriksson et al.

    Insulin-like growth factors (IGF) I and II and IGF binding proteins (IGFBPs) in human colostrum/transitory milk during the first week postpartum: comparison with neonatal and maternal serum

    Biochemical and Biophysical Research Communications

    (1993)
  • J. Feng et al.

    Heparin-binding epidermal growth factor-like growth factor promotes enterocyte migration and proliferation in neonatal rats with necrotizing enterocolitis

    Journal of Pediatrics Surgery

    (2007)
  • M. Fujihara et al.

    Molecular mechanisms of macrophage activation and deactivation by lipopolysaccharide: roles of the receptor complex

    Pharmacology & Therapeutics

    (2003)
  • M. Furukawa et al.

    Presence of platelet-activating factor-acetylhydrolase in milk

    Journal of Lipid Research

    (1993)
  • C. Gao et al.

    S-nitrosylation of heterogeneous nuclear ribonucleoprotein A/B regulates osteopontin transcription in endotoxin-stimulated murine macrophages

    Journal of Biological Chemistry

    (2004)
  • S.E. Gill et al.

    Metalloproteinases and their inhibitors: regulators of wound healing

    International Journal of Biochemistry and Cell Biology

    (2008)
  • H. Guo et al.

    Osteopontin mediates Stat1 degradation to inhibit iNOS transcription in a cecal ligation and puncture model of sepsis

    Surgery

    (2008)
  • M. Hamosh et al.

    Protective function of human milk: the milk fat globule

    Seminars in Perinatology

    (1999)
  • L. Haversen et al.

    Lactoferrin down-regulates the LPS-induced cytokine production in monocytic cells via NF-kappa B

    Cellular Immunology

    (2002)
  • K. Adel-Patient et al.

    Oral tolerance and Treg cells are induced in BALB/c mice after gavage with bovine beta-lactoglobulin

    Allergy

    (2011)
  • P. Aisen et al.

    Iron transport and storage proteins

    Annual Review of Biochemistry

    (1980)
  • S. Akira et al.

    Toll-like receptors and their signaling mechanisms

    Scandinavian Journal of Infectious Diseases

    (2003)
  • L. An et al.

    Heme oxygenase-1 system, inflammation and ventilator-induced lung injury

    European Journal of Pharmacology

    (2011)
  • M.H. Andersen et al.

    Bovine PAS-6/7 binds alpha v beta 5 integrins and anionic phospholipids through two domains

    Biochemistry

    (1997)
  • M.H. Andersen et al.

    Functional analyses of two cellular binding domains of bovine lactadherin

    Biochemistry

    (2000)
  • B.F. Anderson et al.

    Structure of human lactoferrin at 3.2-A resolution

    Proceedings of the National Academy of Sciences United States of America

    (1987)
  • K. Ando et al.

    Human lactoferrin activates NF-kappaB through the Toll-like receptor 4 pathway while it interferes with the lipopolysaccharide-stimulated TLR4 signaling

    FEBS Journal

    (2010)
  • B.J. Appelmelk et al.

    Lactoferrin is a lipid A-binding protein

    Infection and Immunity

    (1994)
  • M. Asano et al.

    Polymeric immunoglobulin receptor

    Journal of Oral Science

    (2011)
  • A. Ashare et al.

    Anti-inflammatory response is associated with mortality and severity of infection in sepsis

    American Journal of Physiology-Lung Cellular and Molecular Physiology

    (2005)
  • Cited by (309)

    View all citing articles on Scopus
    View full text